The patient is a Nigeria resident who likely contracted the infection there before traveling to the United Kingdom.
The US Food and Drug Administration (FDA) today approved TPOXX (tecovirimat), made by SIGA Technologies, as the first drug with an indication for treating smallpox, a disease that has been eradicated but could still be used as a bioweapon.
Ten more illnesses have been reported in a multistate Salmonella outbreak linked to precut melon, pushing the total to 70, and two more states have reported cases, the US Centers for Disease Control and Prevention (CDC) said today in an update.
US flu levels fell sharply again last week with the approach of summer, but the Centers for Disease Control and Prevention (CDC) recorded three more pediatric flu deaths, according to the latest weekly update posted today.
Flu was reported as widespread in only two states: Massachusetts and New York.
Scientists in China are reporting the emergence of a new strain of hypervirulent, carbapenem-resistant of Klebsiella pneumoniae.
A report yesterday from Brazil's Ministry of Health (MOH) said there are now 723 confirmed cases of yellow fever, including 237 deaths, in that country from Jul 1, 2017, to Feb 28 of this year. That number includes 259 new cases detected in February.
Bavarian Nordic today announced promising findings for a phase 3 study of its smallpox vaccine Imvamune, which compared its efficacy against ACAM200, the smallpox vaccine currently licensed in the United States. Imvamune is a nonreplicating vaccine designed to be safer for use in patients who shouldn't be given the replicating vaccine, such as those with atopic dermatitis or HIV.
SIGA Technologies of New York City announced yesterday that it has submitted its smallpox drug TPOXX (tecovirimat) for priority review by the US Food and Drug Administration (FDA).
The outbreak has now become Nigeria's largest ever, with 9 confirmed cases.
The positive results shed light on what could be one of the largest monkeypox outbreaks in Africa.
